Canada's federal government has dismissed, for the time being, the notion that the country's supplies of prescription drugs is under threat from the possibility of massive exportation to the USA. The claim has been circulating as the result of recent legislative moves by US Senator David Vitter (Republican, Louisiana) and the presumed support of the newly-elected Democratic majority in both Houses of Congress (Marketletters passim).
The Canadian Pharmacists Association recently wrote to Canada's federal Health Minister, Tony Clement, warning that "full-blown" legalization of parallel trade by the USA would suck Canada's cheaper prescription drugs southwards into a larger and more profitable market (Marketletter October 30). One study, put forward by supporters of a ban on Canadian exports, claims that Canada has only 38 days of drug supplies, although the relevance of this figure when compared with other national stocks of important goods is open to question.
Opening US border could be years away
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze